Trials / Completed
CompletedNCT05702892
Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases
Evaluation Of Biomarkers Associated With Bone Metabolism İn Patients With Different Periodontal Status
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Necmettin Erbakan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the levels of biomarkers associated with bone metabolism in patients with different periodontal conditions.
Detailed description
Background: In this study, the levels of bone metabolism markers found in the saliva of individuals with different periodontal conditions were compared and the relationship of these markers with periodontal status was examined. Method: A total of 60 individuals, 20 with periodontitis (P), 20 with gingivitis (G), and 20 with periodontal healthy (S), were included in the study. Periodontal clinical parameters (plaque index, gingival index, bleeding on probing, clinical attachment level and probing pocket depth) and saliva samples were obtained from the individuals. Bone metabolism biomarker (necrotizing factor (TNF)-α, osteoprotegerin (OPG), nuclear factor kappa-β receptor activator ligand (RANKL) and sclerostin) levels in saliva samples were evaluated by enzyme-linked immunosorbent assay (ELISA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ELISA | ELISA(enzyme-linked immunosorbent assay) |
Timeline
- Start date
- 2020-11-05
- Primary completion
- 2021-05-05
- Completion
- 2021-11-05
- First posted
- 2023-01-27
- Last updated
- 2023-01-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05702892. Inclusion in this directory is not an endorsement.